# Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

> **NCT00006225** · PHASE1,PHASE2 · COMPLETED · sponsor: **Northwestern University**

## Conditions studied

- Breast Cancer
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic/Myeloproliferative Diseases

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** recombinant flt3 ligand
- **BIOLOGICAL:** recombinant human thrombopoietin
- **BIOLOGICAL:** recombinant interleukin-3
- **PROCEDURE:** in vitro-treated peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00006225
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** 2004-01
- **Final completion:** 2004-01
- **Target enrollment:** — (—)
- **Last updated:** 2012-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006225, "Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00006225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*